Skip to main content
. 2014 Dec 22;2014:973406. doi: 10.1155/2014/973406

(a).

Combination positive (n)/negative (n)/specificity (%) 230/253/64.2%
Tumors detected (n)/sensitivity (%) 103/80.5%
High-risk tumors detected (n)/sensitivity (%) 47/94%
Numbers of tumors missed (n)/NPV (%) 25/90.1%
Numbers of high-risk tumors missed (n)/NPV (%) 3/98.8%
Numbers of false positive tests (n)/PPV (%) 127/44.7%
Additional tumors detected (n)/additional high-risk tumors detected by uCyt+ (n) 14/4